5-Bromo-2-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 250mg

N-(2-(2-(2-(3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamido)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 90%, 1g

5-(2,3-dichlorophenyl)-5-oxovaleric acid, 97.0%, 2g

3-Hydroxy-4-methylbenzonitrile, 97.0%, 100g

1,3-Dibromo-5-(2-ethylhexyl)-4H-thieno[3,4-c]pyrrole-4,6(5H)-dione, 98%, 1g

4-(Thiophen-2-yl)aniline, 95.0%, 5g

(S)-N-4-Boc-N-1-Cbz-2-Piperazine carboxylic acid, 98.0%, 250mg

2-Chloro-1-naphthoic acid, 97%, 1g

3',5'-DIMETHOXY-4',5,7-TRIHYDROXYFLAVONE, 95%, 250mg

2-N-phenylpyridine-2,4-diamine, 97%, 250mg

(E)-5-[(2-Dimethylamino-ethyl)-methyl-amino]-1-phenyl-pent-1-en-3-one, 95.0%, 1g

Lithium Bromide>99.0%(T)25g

Ethylene Glycol Monoallyl Ether>98.0%(GC)500mL